POCUS

Alberta Innovates Provides $12.4 million to Advance Health Innovations

Retrieved on: 
Monday, February 26, 2024

Dr. Abhilash Hareendranathan, from the Faculty of Medicine and Dentistry at the University of Alberta, is a recipient of an Accelerating Innovations into Care (AICE)-Concepts award from Alberta Innovates , and believes he has an answer to that question.

Key Points: 
  • Dr. Abhilash Hareendranathan, from the Faculty of Medicine and Dentistry at the University of Alberta, is a recipient of an Accelerating Innovations into Care (AICE)-Concepts award from Alberta Innovates , and believes he has an answer to that question.
  • This unique opportunity is part of the suite of AICE programs designed to advance health technologies toward market adoption with the aim of providing positive economic and health impacts for Alberta.
  • This year, 10 awards are being provided to researchers and innovators around Alberta for a total of $6.1 million.
  • We’re grateful that Alberta Innovates supports our researchers’ efforts to get their life-changing innovations from the lab to the bedside, to help improve outcomes for patients in Alberta and beyond.

Wellstar MCG Health Implements Exo Works™ and Sees 47% Increase in Revenue Capture

Retrieved on: 
Tuesday, March 5, 2024

Working with Exo, Wellstar MCG Health has transformed its workflow to streamline imaging, QA, and documentation processes for staff to accommodate the rigorous demands of its emergency and internal medicine departments.

Key Points: 
  • Working with Exo, Wellstar MCG Health has transformed its workflow to streamline imaging, QA, and documentation processes for staff to accommodate the rigorous demands of its emergency and internal medicine departments.
  • As a result, Wellstar MCG Health has been able to break even on its investment in Exo Works a mere three months following its implementation.
  • “Working with Exo to get Exo Works implemented has been an outstanding experience,” said Lee LaRavia, DO, FACEP, Director of Emergency and Clinical Ultrasound at Wellstar MCG Health.
  • “Wellstar MCG Health is dedicated to expanding access to the benefits of POCUS everywhere, which is at the heart of Exo’s vision.

Butterfly Network Reports Fourth Quarter 2023 Financial Results

Retrieved on: 
Wednesday, February 28, 2024

Mendaera Agreement: On December 19, 2023, Butterfly announced an agreement to commercialize a novel robotic system that is Powered by Butterfly’s Ultrasound-on-Chip™ technology.

Key Points: 
  • Mendaera Agreement: On December 19, 2023, Butterfly announced an agreement to commercialize a novel robotic system that is Powered by Butterfly’s Ultrasound-on-Chip™ technology.
  • Forest Neurotech Agreement: On October 24, 2023, Butterfly announced that it had entered into a five-year co-development agreement with Forest Neurotech.
  • Three Months Ended December 31, 2023 Financial Results
    Revenue: Total revenue was $16.5 million, down from $19.0 million in the fourth quarter of 2022.
  • An explanation of these non-GAAP financial measures is also included below under the heading “Non-GAAP Financial Measures.”
    A conference call and webcast to discuss the fourth quarter and full year 2023 financial results and operational progress is scheduled for 5:00 pm ET, February 28, 2024.

GE HealthCare Showcases Precision Care with Launch of Elevated LOGIQ Ultrasound System Portfolio at European Congress of Radiology 2024

Retrieved on: 
Wednesday, February 28, 2024

GE HealthCare (Nasdaq: GEHC) today announced its latest innovation in ultrasound with the launch of its next-level LOGIQ ultrasound portfolio—including the new LOGIQ Totus—highlighting the company’s progress in advancing precision care.

Key Points: 
  • GE HealthCare (Nasdaq: GEHC) today announced its latest innovation in ultrasound with the launch of its next-level LOGIQ ultrasound portfolio—including the new LOGIQ Totus—highlighting the company’s progress in advancing precision care.
  • “At GE HealthCare, we’re focused on driving innovation that enables precision care, and the enhanced LOGIQ portfolio allows us to deliver on this promise with products and solutions that help clinicians optimize care with ease and efficiency,” said Jyoti Gera, General Manager, General Imaging and Primary Care, Ultrasound at GE HealthCare.
  • With LOGIQ AppAPI, GE HealthCare can collaborate with third parties on applications that run directly on the LOGIQ system or use real-time streaming of ultrasound data to run side-by-side with the LOGIQ system.
  • GE HealthCare will demonstrate the next-generation LOGIQ portfolio at the European Congress of Radiology (ECR) on February 28 to March 3 in Vienna.

Butterfly Network Launches Next-Generation Butterfly iQ3™ in the United States

Retrieved on: 
Tuesday, February 13, 2024

Butterfly iQ3 is powered by the Company’s most advanced semiconductor chip with a data transfer rate that is double that of its predecessor.

Key Points: 
  • Butterfly iQ3 is powered by the Company’s most advanced semiconductor chip with a data transfer rate that is double that of its predecessor.
  • View the full release here: https://www.businesswire.com/news/home/20240213652085/en/
    The Butterfly iQ3 device featuring a new user-centric ergonomic design that is smaller, lighter and better weight distributed.
  • The introduction of Butterfly iQ3 includes a focus on higher precision capabilities for cardiovascular point-of-care ultrasound applications to inform complex decisions.
  • Butterfly Network’s Chief Medical Officer, John Martin, MD, concludes, “With Butterfly iQ3, we set out to give clinicians the clear leading solution in point-of-care ultrasound.

Inteleos and Credivera Partner to Revolutionize Global Healthcare Credentialing

Retrieved on: 
Monday, February 5, 2024

ROCKVILLE, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- In a groundbreaking partnership, Inteleos a non-profit global healthcare certification organization, is collaborating with Credivera to transform global healthcare credentialing through the addition of digital identities and verifiable credentials.

Key Points: 
  • ROCKVILLE, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- In a groundbreaking partnership, Inteleos a non-profit global healthcare certification organization, is collaborating with Credivera to transform global healthcare credentialing through the addition of digital identities and verifiable credentials.
  • The program will address critical issues in the healthcare industry, including fraud prevention and the streamlining of credential verification processes.
  • The digital wallet can hold a variety of other credentials, with a focus on Inteleos’ collaboration with continuing education (CE) providers.
  • Inteleos’ partnership with Credivera signals to the certification community that Inteleos is taking a bold step in this direction.

UltraSight Partners with SELVAS Healthcare to Develop and Commercialize AI-Powered Cardiac Ultrasound Software in Asia

Retrieved on: 
Monday, February 5, 2024

TEL AVIV, Israel, Feb. 5, 2024 /PRNewswire/ -- Today, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced a partnership with SELVAS Healthcare (subsidiary of SELVAS Group), a Korean-based global digital healthcare company with innovative technology in medical device manufacturing and software. This new joint venture kicks off the introduction of UltraSight's real-time AI guidance technology in Asia, beginning with the regulatory process for approvals that may lead to eventual commercialization and distribution in Korea and the Southeast Asian market.

Key Points: 
  • "At UltraSight, our mission is to expand access to cardiac care by empowering medical professionals to conduct high-quality cardiac ultrasound with minimal training, both inside and outside the hospital," said UltraSight CEO Davidi Vortman.
  • "We aim to address the significant global disparity between the number of cardiovascular disease patients and the availability of cardiac ultrasound.
  • UltraSight's software pairs with point-of-care ultrasound (POCUS) devices to provide medical professionals with real-time guidance to acquire diagnostic-quality cardiac ultrasound images, regardless of experience level.
  • SELVAS Healthcare will have exclusive rights to distribute and commercialize UltraSight's AI cardiac ultrasound technology in Korea.

FUJIFILM Sonosite Introduces Sonosite Voice Assist, a Groundbreaking Voice Command Feature for Point of Care Ultrasound

Retrieved on: 
Thursday, February 1, 2024

The Voice Assist is easily activated with a simple voice command, “Activate Voice,” whereby proceduralists are immediately able to control many of the critical functions hands-free during an exam.

Key Points: 
  • The Voice Assist is easily activated with a simple voice command, “Activate Voice,” whereby proceduralists are immediately able to control many of the critical functions hands-free during an exam.
  • FUJIFILM Sonosite’s Voice Assist feature allows users to freeze and save images, adjust gain settings, and add color flow all through the proceduralists voice command.
  • Additionally, the hands-free operation allows the proceduralist to stay fully focused on the patient, contributing to a safer, more sterile environment.
  • “This groundbreaking advancement demonstrates FUJIFILM Sonosite’s commitment to not only enhancing its products but also improving patient care and empowering healthcare professionals to deliver the best possible medical services," said Rich Fabian, chief executive officer and president of FUJIFILM Sonosite.

Butterfly Network Provides Business Update During 42nd Annual J.P. Morgan Healthcare Conference Presentation

Retrieved on: 
Thursday, January 11, 2024

Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, provided a business update today at the 42nd Annual J.P. Morgan Healthcare Conference.

Key Points: 
  • Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, provided a business update today at the 42nd Annual J.P. Morgan Healthcare Conference.
  • A webcast replay of the conference presentation can be viewed here , and will be available until February 10th, 2024.
  • Earlier this week, Butterfly announced that the FDA granted clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3.
  • DeVivo continued, “Four days ago, we announced that we received FDA clearance for our third-generation device, Butterfly iQ3.

Butterfly Network Announces FDA Clearance of its Next-Generation Handheld Ultrasound System, Butterfly iQ3

Retrieved on: 
Monday, January 8, 2024

Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced the FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3.

Key Points: 
  • Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced the FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3.
  • The new device is the company’s third iteration of the world’s first semiconductor-based single-probe, whole-body ultrasound system.
  • Butterfly started a revolution in ultrasound when we commercialized the world’s first fully digital handheld ultrasound in 2018, and subsequently, iQ+ in 2020,” said Joseph DeVivo, Butterfly Network’s President, Chief Executive Officer and Chairman.
  • To stay up to date with the latest Butterfly iQ3 launch news, subscribe here .